Szpakowska et al. also examined conolidone and its motion on the ACKR3 receptor, which allows to clarify its Formerly unidentified system of action in equally acute and Persistent pain control (fifty eight). It had been discovered that receptor amounts of ACKR3 were as high and even greater as People on the endogenous opiate process and were being